|
AU2018250823A1
|
|
Compositions for treating addiction
|
|
AU2016202521A1
|
|
Enzyme delivery systems and methods of preparations and use
|
|
AU2015215910A1
|
|
Enzyme delivery systems and methods of preparations and use
|
|
AU2013224726A1
|
|
Enzyme delivery systems and methods of preparations and use
|
|
US2013323223A1
|
|
Methods of treating Celiac disease
|
|
CN108578684A
|
|
The method for the treatment of nerve and the behavior symptom of phrenoblabia
|
|
NZ716627A
|
|
Methods of treating behavioral symptoms of neurological and mental disorders
|
|
CN106310242A
|
|
Compounds for the treatment of neuropsychiatric disorders
|
|
CA2815044A1
|
|
Preparation and use of combination enzyme and gastrointestinal modulator delivery systems
|
|
CN105435217A
|
|
Enzyme delivery systems and methods of preparations and use
|
|
CA2747703A1
|
|
Compositions and methods for the treatment or the prevention of infections by e. coli
|
|
US8030002B2
|
|
Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
|
